English
简体中文
Total: £ 56.28
Published Date: 2025-08-11 | Pages: 86 | Tables: 83 | Pharma & Healthcare
The global market for Fibrinogen for Injection was valued at US$ 468 million in the year 2024 and is projected to reach a revised size of US$ 753 million by 2031, growing at a CAGR of 7.2% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Fibrinogen for Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Fibrinogen for Injection is a sterile, lyophilized (freeze-dried) plasma-derived product used to treat acute bleeding episodes in patients with congenital or acquired fibrinogen deficiency. As a critical protein in the blood coagulation cascade, fibrinogen is essential for clot formation and wound healing. This injectable form is reconstituted with sterile water and administered intravenously to rapidly restore fibrinogen levels, helping to control bleeding during surgery, trauma, or in patients with conditions like afibrinogenemia or dysfibrinogenemia. It offers a targeted, fast-acting solution when timely clot formation is crucial for patient outcomes. In 2024, global fibrinogen for Injection sales reached approximately 3342 k vitals, with an average global market price of around US$ 140 per vital.
North American market for Fibrinogen for Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Fibrinogen for Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Fibrinogen for Injection include CSL Behring, LFB Biopharmaceuticals, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, Taibang Biologic, Octapharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Fibrinogen for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fibrinogen for Injection.
The Fibrinogen for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Vitals) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Fibrinogen for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fibrinogen for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
CSL Behring
LFB Biopharmaceuticals
Shanghai RAAS Blood Products
Jiangxi Boya Bio-Pharmaceutical
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
Taibang Biologic
Octapharma
Segment by Type
0.5g/Vital
1.0g/Vital
Segment by Application
Congenital Hypofibrinogenemia
Acquired Hypofibrinogenemia
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fibrinogen for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fibrinogen for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Fibrinogen for Injection Market Overview
1.1 Product Definition
1.2 Fibrinogen for Injection by Type
1.2.1 Global Fibrinogen for Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 0.5g/Vital
1.2.3 1.0g/Vital
1.3 Fibrinogen for Injection by Application
1.3.1 Global Fibrinogen for Injection Market Value by Application (2024 VS 2031)
1.3.2 Congenital Hypofibrinogenemia
1.3.3 Acquired Hypofibrinogenemia
1.4 Global Fibrinogen for Injection Market Size Estimates and Forecasts
1.4.1 Global Fibrinogen for Injection Revenue 2020-2031
1.4.2 Global Fibrinogen for Injection Sales 2020-2031
1.4.3 Global Fibrinogen for Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Fibrinogen for Injection Market Competition by Manufacturers
2.1 Global Fibrinogen for Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Fibrinogen for Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Fibrinogen for Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Fibrinogen for Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Fibrinogen for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fibrinogen for Injection, Product Type & Application
2.7 Global Key Manufacturers of Fibrinogen for Injection, Date of Enter into This Industry
2.8 Global Fibrinogen for Injection Market Competitive Situation and Trends
2.8.1 Global Fibrinogen for Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Fibrinogen for Injection Players Market Share by Revenue
2.8.3 Global Fibrinogen for Injection Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Fibrinogen for Injection Market Scenario by Region
3.1 Global Fibrinogen for Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Fibrinogen for Injection Sales by Region: 2020-2031
3.2.1 Global Fibrinogen for Injection Sales by Region: 2020-2025
3.2.2 Global Fibrinogen for Injection Sales by Region: 2026-2031
3.3 Global Fibrinogen for Injection Revenue by Region: 2020-2031
3.3.1 Global Fibrinogen for Injection Revenue by Region: 2020-2025
3.3.2 Global Fibrinogen for Injection Revenue by Region: 2026-2031
3.4 North America Fibrinogen for Injection Market Facts & Figures by Country
3.4.1 North America Fibrinogen for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Fibrinogen for Injection Sales by Country (2020-2031)
3.4.3 North America Fibrinogen for Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Fibrinogen for Injection Market Facts & Figures by Country
3.5.1 Europe Fibrinogen for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Fibrinogen for Injection Sales by Country (2020-2031)
3.5.3 Europe Fibrinogen for Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fibrinogen for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Fibrinogen for Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Fibrinogen for Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Fibrinogen for Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Fibrinogen for Injection Market Facts & Figures by Country
3.7.1 Latin America Fibrinogen for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Fibrinogen for Injection Sales by Country (2020-2031)
3.7.3 Latin America Fibrinogen for Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Fibrinogen for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Fibrinogen for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Fibrinogen for Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Fibrinogen for Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fibrinogen for Injection Sales by Type (2020-2031)
4.1.1 Global Fibrinogen for Injection Sales by Type (2020-2025)
4.1.2 Global Fibrinogen for Injection Sales by Type (2026-2031)
4.1.3 Global Fibrinogen for Injection Sales Market Share by Type (2020-2031)
4.2 Global Fibrinogen for Injection Revenue by Type (2020-2031)
4.2.1 Global Fibrinogen for Injection Revenue by Type (2020-2025)
4.2.2 Global Fibrinogen for Injection Revenue by Type (2026-2031)
4.2.3 Global Fibrinogen for Injection Revenue Market Share by Type (2020-2031)
4.3 Global Fibrinogen for Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Fibrinogen for Injection Sales by Application (2020-2031)
5.1.1 Global Fibrinogen for Injection Sales by Application (2020-2025)
5.1.2 Global Fibrinogen for Injection Sales by Application (2026-2031)
5.1.3 Global Fibrinogen for Injection Sales Market Share by Application (2020-2031)
5.2 Global Fibrinogen for Injection Revenue by Application (2020-2031)
5.2.1 Global Fibrinogen for Injection Revenue by Application (2020-2025)
5.2.2 Global Fibrinogen for Injection Revenue by Application (2026-2031)
5.2.3 Global Fibrinogen for Injection Revenue Market Share by Application (2020-2031)
5.3 Global Fibrinogen for Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Company Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Fibrinogen for Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 CSL Behring Fibrinogen for Injection Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 LFB Biopharmaceuticals
6.2.1 LFB Biopharmaceuticals Company Information
6.2.2 LFB Biopharmaceuticals Description and Business Overview
6.2.3 LFB Biopharmaceuticals Fibrinogen for Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 LFB Biopharmaceuticals Fibrinogen for Injection Product Portfolio
6.2.5 LFB Biopharmaceuticals Recent Developments/Updates
6.3 Shanghai RAAS Blood Products
6.3.1 Shanghai RAAS Blood Products Company Information
6.3.2 Shanghai RAAS Blood Products Description and Business Overview
6.3.3 Shanghai RAAS Blood Products Fibrinogen for Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Shanghai RAAS Blood Products Fibrinogen for Injection Product Portfolio
6.3.5 Shanghai RAAS Blood Products Recent Developments/Updates
6.4 Jiangxi Boya Bio-Pharmaceutical
6.4.1 Jiangxi Boya Bio-Pharmaceutical Company Information
6.4.2 Jiangxi Boya Bio-Pharmaceutical Description and Business Overview
6.4.3 Jiangxi Boya Bio-Pharmaceutical Fibrinogen for Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Jiangxi Boya Bio-Pharmaceutical Fibrinogen for Injection Product Portfolio
6.4.5 Jiangxi Boya Bio-Pharmaceutical Recent Developments/Updates
6.5 Hualan Biological Engineering
6.5.1 Hualan Biological Engineering Company Information
6.5.2 Hualan Biological Engineering Description and Business Overview
6.5.3 Hualan Biological Engineering Fibrinogen for Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Hualan Biological Engineering Fibrinogen for Injection Product Portfolio
6.5.5 Hualan Biological Engineering Recent Developments/Updates
6.6 Harbin Pacific Biopharmaceutical
6.6.1 Harbin Pacific Biopharmaceutical Company Information
6.6.2 Harbin Pacific Biopharmaceutical Description and Business Overview
6.6.3 Harbin Pacific Biopharmaceutical Fibrinogen for Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Harbin Pacific Biopharmaceutical Fibrinogen for Injection Product Portfolio
6.6.5 Harbin Pacific Biopharmaceutical Recent Developments/Updates
6.7 Taibang Biologic
6.7.1 Taibang Biologic Company Information
6.7.2 Taibang Biologic Description and Business Overview
6.7.3 Taibang Biologic Fibrinogen for Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Taibang Biologic Fibrinogen for Injection Product Portfolio
6.7.5 Taibang Biologic Recent Developments/Updates
6.8 Octapharma
6.8.1 Octapharma Company Information
6.8.2 Octapharma Description and Business Overview
6.8.3 Octapharma Fibrinogen for Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Octapharma Fibrinogen for Injection Product Portfolio
6.8.5 Octapharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fibrinogen for Injection Industry Chain Analysis
7.2 Fibrinogen for Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fibrinogen for Injection Production Mode & Process Analysis
7.4 Fibrinogen for Injection Sales and Marketing
7.4.1 Fibrinogen for Injection Sales Channels
7.4.2 Fibrinogen for Injection Distributors
7.5 Fibrinogen for Injection Customer Analysis
8 Fibrinogen for Injection Market Dynamics
8.1 Fibrinogen for Injection Industry Trends
8.2 Fibrinogen for Injection Market Drivers
8.3 Fibrinogen for Injection Market Challenges
8.4 Fibrinogen for Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Fibrinogen for Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Fibrinogen for Injection Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Fibrinogen for Injection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Fibrinogen for Injection Sales (K Vitals) of Key Manufacturers (2020-2025)
Table 5. Global Fibrinogen for Injection Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Fibrinogen for Injection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Fibrinogen for Injection Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Fibrinogen for Injection Average Price (US$/Vital) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Fibrinogen for Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Fibrinogen for Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Fibrinogen for Injection, Product Type & Application
Table 12. Global Key Manufacturers of Fibrinogen for Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Fibrinogen for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibrinogen for Injection as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Fibrinogen for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Fibrinogen for Injection Sales by Region (2020-2025) & (K Vitals)
Table 18. Global Fibrinogen for Injection Sales Market Share by Region (2020-2025)
Table 19. Global Fibrinogen for Injection Sales by Region (2026-2031) & (K Vitals)
Table 20. Global Fibrinogen for Injection Sales Market Share by Region (2026-2031)
Table 21. Global Fibrinogen for Injection Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Fibrinogen for Injection Revenue Market Share by Region (2020-2025)
Table 23. Global Fibrinogen for Injection Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Fibrinogen for Injection Revenue Market Share by Region (2026-2031)
Table 25. North America Fibrinogen for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Fibrinogen for Injection Sales by Country (2020-2025) & (K Vitals)
Table 27. North America Fibrinogen for Injection Sales by Country (2026-2031) & (K Vitals)
Table 28. North America Fibrinogen for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Fibrinogen for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Fibrinogen for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Fibrinogen for Injection Sales by Country (2020-2025) & (K Vitals)
Table 32. Europe Fibrinogen for Injection Sales by Country (2026-2031) & (K Vitals)
Table 33. Europe Fibrinogen for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Fibrinogen for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Fibrinogen for Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Fibrinogen for Injection Sales by Region (2020-2025) & (K Vitals)
Table 37. Asia Pacific Fibrinogen for Injection Sales by Region (2026-2031) & (K Vitals)
Table 38. Asia Pacific Fibrinogen for Injection Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Fibrinogen for Injection Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Fibrinogen for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Fibrinogen for Injection Sales by Country (2020-2025) & (K Vitals)
Table 42. Latin America Fibrinogen for Injection Sales by Country (2026-2031) & (K Vitals)
Table 43. Latin America Fibrinogen for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Fibrinogen for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Fibrinogen for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Fibrinogen for Injection Sales by Country (2020-2025) & (K Vitals)
Table 47. Middle East and Africa Fibrinogen for Injection Sales by Country (2026-2031) & (K Vitals)
Table 48. Middle East and Africa Fibrinogen for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Fibrinogen for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Fibrinogen for Injection Sales (K Vitals) by Type (2020-2025)
Table 51. Global Fibrinogen for Injection Sales (K Vitals) by Type (2026-2031)
Table 52. Global Fibrinogen for Injection Sales Market Share by Type (2020-2025)
Table 53. Global Fibrinogen for Injection Sales Market Share by Type (2026-2031)
Table 54. Global Fibrinogen for Injection Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Fibrinogen for Injection Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Fibrinogen for Injection Revenue Market Share by Type (2020-2025)
Table 57. Global Fibrinogen for Injection Revenue Market Share by Type (2026-2031)
Table 58. Global Fibrinogen for Injection Price (US$/Vital) by Type (2020-2025)
Table 59. Global Fibrinogen for Injection Price (US$/Vital) by Type (2026-2031)
Table 60. Global Fibrinogen for Injection Sales (K Vitals) by Application (2020-2025)
Table 61. Global Fibrinogen for Injection Sales (K Vitals) by Application (2026-2031)
Table 62. Global Fibrinogen for Injection Sales Market Share by Application (2020-2025)
Table 63. Global Fibrinogen for Injection Sales Market Share by Application (2026-2031)
Table 64. Global Fibrinogen for Injection Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Fibrinogen for Injection Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Fibrinogen for Injection Revenue Market Share by Application (2020-2025)
Table 67. Global Fibrinogen for Injection Revenue Market Share by Application (2026-2031)
Table 68. Global Fibrinogen for Injection Price (US$/Vital) by Application (2020-2025)
Table 69. Global Fibrinogen for Injection Price (US$/Vital) by Application (2026-2031)
Table 70. CSL Behring Company Information
Table 71. CSL Behring Description and Business Overview
Table 72. CSL Behring Fibrinogen for Injection Sales (K Vitals), Revenue (US$ Million), Price (US$/Vital) and Gross Margin (2020-2025)
Table 73. CSL Behring Fibrinogen for Injection Product
Table 74. CSL Behring Recent Developments/Updates
Table 75. LFB Biopharmaceuticals Company Information
Table 76. LFB Biopharmaceuticals Description and Business Overview
Table 77. LFB Biopharmaceuticals Fibrinogen for Injection Sales (K Vitals), Revenue (US$ Million), Price (US$/Vital) and Gross Margin (2020-2025)
Table 78. LFB Biopharmaceuticals Fibrinogen for Injection Product
Table 79. LFB Biopharmaceuticals Recent Developments/Updates
Table 80. Shanghai RAAS Blood Products Company Information
Table 81. Shanghai RAAS Blood Products Description and Business Overview
Table 82. Shanghai RAAS Blood Products Fibrinogen for Injection Sales (K Vitals), Revenue (US$ Million), Price (US$/Vital) and Gross Margin (2020-2025)
Table 83. Shanghai RAAS Blood Products Fibrinogen for Injection Product
Table 84. Shanghai RAAS Blood Products Recent Developments/Updates
Table 85. Jiangxi Boya Bio-Pharmaceutical Company Information
Table 86. Jiangxi Boya Bio-Pharmaceutical Description and Business Overview
Table 87. Jiangxi Boya Bio-Pharmaceutical Fibrinogen for Injection Sales (K Vitals), Revenue (US$ Million), Price (US$/Vital) and Gross Margin (2020-2025)
Table 88. Jiangxi Boya Bio-Pharmaceutical Fibrinogen for Injection Product
Table 89. Jiangxi Boya Bio-Pharmaceutical Recent Developments/Updates
Table 90. Hualan Biological Engineering Company Information
Table 91. Hualan Biological Engineering Description and Business Overview
Table 92. Hualan Biological Engineering Fibrinogen for Injection Sales (K Vitals), Revenue (US$ Million), Price (US$/Vital) and Gross Margin (2020-2025)
Table 93. Hualan Biological Engineering Fibrinogen for Injection Product
Table 94. Hualan Biological Engineering Recent Developments/Updates
Table 95. Harbin Pacific Biopharmaceutical Company Information
Table 96. Harbin Pacific Biopharmaceutical Description and Business Overview
Table 97. Harbin Pacific Biopharmaceutical Fibrinogen for Injection Sales (K Vitals), Revenue (US$ Million), Price (US$/Vital) and Gross Margin (2020-2025)
Table 98. Harbin Pacific Biopharmaceutical Fibrinogen for Injection Product
Table 99. Harbin Pacific Biopharmaceutical Recent Developments/Updates
Table 100. Taibang Biologic Company Information
Table 101. Taibang Biologic Description and Business Overview
Table 102. Taibang Biologic Fibrinogen for Injection Sales (K Vitals), Revenue (US$ Million), Price (US$/Vital) and Gross Margin (2020-2025)
Table 103. Taibang Biologic Fibrinogen for Injection Product
Table 104. Taibang Biologic Recent Developments/Updates
Table 105. Octapharma Company Information
Table 106. Octapharma Description and Business Overview
Table 107. Octapharma Fibrinogen for Injection Sales (K Vitals), Revenue (US$ Million), Price (US$/Vital) and Gross Margin (2020-2025)
Table 108. Octapharma Fibrinogen for Injection Product
Table 109. Octapharma Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Fibrinogen for Injection Distributors List
Table 113. Fibrinogen for Injection Customers List
Table 114. Fibrinogen for Injection Market Trends
Table 115. Fibrinogen for Injection Market Drivers
Table 116. Fibrinogen for Injection Market Challenges
Table 117. Fibrinogen for Injection Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Fibrinogen for Injection
Figure 2. Global Fibrinogen for Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Fibrinogen for Injection Market Share by Type: 2024 & 2031
Figure 4. 0.5g/Vital Product Picture
Figure 5. 1.0g/Vital Product Picture
Figure 6. Global Fibrinogen for Injection Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Fibrinogen for Injection Market Share by Application: 2024 & 2031
Figure 8. Congenital Hypofibrinogenemia
Figure 9. Acquired Hypofibrinogenemia
Figure 10. Global Fibrinogen for Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Fibrinogen for Injection Market Size (2020-2031) & (US$ Million)
Figure 12. Global Fibrinogen for Injection Sales (2020-2031) & (K Vitals)
Figure 13. Global Fibrinogen for Injection Average Price (US$/Vital) & (2020-2031)
Figure 14. Fibrinogen for Injection Report Years Considered
Figure 15. Fibrinogen for Injection Sales Share by Manufacturers in 2024
Figure 16. Global Fibrinogen for Injection Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Fibrinogen for Injection Players: Market Share by Revenue in Fibrinogen for Injection in 2024
Figure 18. Fibrinogen for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Fibrinogen for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Fibrinogen for Injection Sales Market Share by Country (2020-2031)
Figure 21. North America Fibrinogen for Injection Revenue Market Share by Country (2020-2031)
Figure 22. United States Fibrinogen for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Fibrinogen for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Fibrinogen for Injection Sales Market Share by Country (2020-2031)
Figure 25. Europe Fibrinogen for Injection Revenue Market Share by Country (2020-2031)
Figure 26. Germany Fibrinogen for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Fibrinogen for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Fibrinogen for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Fibrinogen for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Fibrinogen for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Fibrinogen for Injection Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Fibrinogen for Injection Revenue Market Share by Region (2020-2031)
Figure 33. China Fibrinogen for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Fibrinogen for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Fibrinogen for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Fibrinogen for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Fibrinogen for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Fibrinogen for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Fibrinogen for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Latin America Fibrinogen for Injection Sales Market Share by Country (2020-2031)
Figure 41. Latin America Fibrinogen for Injection Revenue Market Share by Country (2020-2031)
Figure 42. Mexico Fibrinogen for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Brazil Fibrinogen for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Argentina Fibrinogen for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Colombia Fibrinogen for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Fibrinogen for Injection Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Fibrinogen for Injection Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Fibrinogen for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Fibrinogen for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Fibrinogen for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Fibrinogen for Injection by Type (2020-2031)
Figure 52. Global Revenue Market Share of Fibrinogen for Injection by Type (2020-2031)
Figure 53. Global Fibrinogen for Injection Price (US$/Vital) by Type (2020-2031)
Figure 54. Global Sales Market Share of Fibrinogen for Injection by Application (2020-2031)
Figure 55. Global Revenue Market Share of Fibrinogen for Injection by Application (2020-2031)
Figure 56. Global Fibrinogen for Injection Price (US$/Vital) by Application (2020-2031)
Figure 57. Fibrinogen for Injection Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
